To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients

ABSTRACT: To evaluate the safety, tolerability, pharmacokinetics and antitumor activity of YYB101 with Irinotecan, patients who are metastatic or recurrent Colorectal Cancer Patients.

DISEASE(S): Colorectal Cancer Recurrent,Colorectal Neoplasms,Colorectal Cancer Metastatic

PROVIDER: 2337706 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR